Literature DB >> 11331204

Analysis of epidermal-type transglutaminase (TGase 3) expression in mouse tissues and cell lines.

K Hitomi1, Y Horio, K Ikura, K Yamanishi, M Maki.   

Abstract

In the formation of the cornified cell envelope in the epidermis, epidermal-type transglutaminase (TGase 3) cross-links a variety of structural proteins. However, its expression in other tissue has not been investigated. Furthermore, no cell line expressing TGase 3 has been found. The tissue distribution of TGase 3 in mice was investigated using reverse-transcription polymerase chain reaction (RT-PCR) and Western blotting analyses. TGase 3 mRNA was expressed in the brain, stomach, spleen, small intestine, testis, skeletal muscle and skin. The stomach and testis expressed TGase 3 protein in size similar to that observed in the epidermis. Screening various cell lines, a gastric human cancer cell line, MKN-1 and mouse neuroblast cell line, neuro2a, were found to express TGase 3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331204     DOI: 10.1016/s1357-2725(01)00033-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

Review 1.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

2.  Functional amyloids in the mouse sperm acrosome.

Authors:  Benoit Guyonnet; Nathan Egge; Gail A Cornwall
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

Review 3.  Transglutaminases: part I-origins, sources, and biotechnological characteristics.

Authors:  Lovaine Duarte; Carla Roberta Matte; Cristiano Valim Bizarro; Marco Antônio Záchia Ayub
Journal:  World J Microbiol Biotechnol       Date:  2020-01-02       Impact factor: 3.312

4.  Reduced inflammatory threshold indicates skin barrier defect in transglutaminase 3 knockout mice.

Authors:  Peter Bognar; Ilona Nemeth; Balazs Mayer; Dora Haluszka; Norbert Wikonkal; Eszter Ostorhazi; Susan John; Mats Paulsson; Neil Smyth; Maria Pasztoi; Edit I Buzas; Robert Szipocs; Attila Kolonics; Erzsebet Temesvari; Sarolta Karpati
Journal:  J Invest Dermatol       Date:  2013-07-24       Impact factor: 8.551

5.  The mouse wellhaarig (we) mutations result from defects in epidermal-type transglutaminase 3 (Tgm3).

Authors:  Brett M Brennan; Minh T Huynh; Mohammed A Rabah; Hailie E Shaw; Jason J Bisaillon; Legairre A Radden; Tu V Nguyen; Thomas R King
Journal:  Mol Genet Metab       Date:  2015-07-15       Impact factor: 4.797

6.  Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues.

Authors:  I R Korponay-Szabó; K Laurila; Z Szondy; T Halttunen; Z Szalai; I Dahlbom; I Rantala; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

7.  Epidermal transglutaminase (TGase 3) is required for proper hair development, but not the formation of the epidermal barrier.

Authors:  Susan John; Lars Thiebach; Christian Frie; Sharada Mokkapati; Manuela Bechtel; Roswitha Nischt; Sally Rosser-Davies; Mats Paulsson; Neil Smyth
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

8.  Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis.

Authors:  Miklós Sárdy; Sarolta Kárpáti; Barbara Merkl; Mats Paulsson; Neil Smyth
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

9.  The UVB-Stimulated Expression of Transglutaminase 1 Is Mediated Predominantly via the NFκB Signaling Pathway: New Evidence of Its Significant Attenuation through the Specific Interruption of the p38/MSK1/NFκBp65 Ser276 Axis.

Authors:  Shuko Terazawa; Shingo Mori; Hiroaki Nakajima; Michitaka Yasuda; Genji Imokawa
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.

Authors:  Xiangbing Wu; Wei Cao; Xu Wang; Jianjun Zhang; Zhongjing Lv; Xing Qin; Yadi Wu; Wantao Chen
Journal:  Mol Cancer       Date:  2013-12-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.